CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials

Even though chemotherapy and immunotherapy emerged to limit continual and unregulated proliferation of cancer cells, currently available therapeutic agents are associated with high toxicity levels and low success rates. Additionally, ongoing multi-targeted therapies are limited only for few carcinog...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalaf, Khalil, Janowicz, Krzysztof, Dyszkiewicz-Konwińska, Marta, Hutchings, Greg, Dompe, Claudia, Moncrieff, Lisa, Jankowski, Maurycy, Machnik, Marta, Oleksiewicz, Urszula, Kocherova, Ievgeniia, Petitte, Jim, Mozdziak, Paul, Shibli, Jamil A., Iżycki, Dariusz, Józkowiak, Małgorzata, Piotrowska-Kempisty, Hanna, Skowroński, Mariusz T., Antosik, Paweł, Kempisty, Bartosz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463827/
https://www.ncbi.nlm.nih.gov/pubmed/32796761
http://dx.doi.org/10.3390/genes11080921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463827/
https://www.ncbi.nlm.nih.gov/pubmed/32796761
http://dx.doi.org/10.3390/genes11080921

Ejemplares similares